Article: ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science

To: SCIENCE EDITORS

Contact: Robert Goldstein of ALS TDI, +1-617-441-7295, rgoldstein@als.net; or Aaron Blank for the Allen Institute for Brain Science, +1-206-343-1543, aaronblank@feareygroup.com

Long-term arrangement between two leading non-profit research institutes designed to validate drug targets for the fatal neurodegenerative disease that affects 30,000 Americans

CAMBRIDGE, Mass.,April 8, 2008/PRNewswire-USNewswire/--The ALS Therapy Development Institute (ALS TDI) today announced it has entered into an agreement with the Allen Institute for Brain Science in Seattle, Wash. for in situhybridization (ISH) services using diseased tissues from a preclinical animal model of amyotrophic ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!